The 2010 ACR-EULAR classification criteria for rheumatoid arthritis.
Arthritis Rheum 2010 Sep;69(9):1580-8. doi:10.1002/art.27584
Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis.
Arthritis Rheum 2007; 56(8):2503-11. – doi:10.1002/art.22817
Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein/peptide antibodies in the diagnosis of rheumatoid arthritis.
Clin Chem 2007; 53(3):498- 504. – doi:10.1373/clinchem.2006.078063
Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis.
Arthritis Res Ther 2006; 8(4):R119.
The Serological Diagnosis of Rheumatoid Arthritis
– Antibodies to citrullinated Antigens [Serologische Diagnostik der rheumatoiden Arthritis: Antikörper gegen citrullinierte Antigene].
Dtsch Arztebl Int 2009; 106(10):159-63 – doi:10.3238/arztebl.2009.0159
Anti-Citrullinated Protein-Peptide Antibodies in Rheumatoid Arthritis [Anticitrullinierte Protein/Peptid-Antikörper bei rheumatoider Arthritis].
Dtsch Arztebl Int 2009; 106(10):157–8 – doi:10.3238/arztebl.2009.0157
Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin.
J Clin Invest. 2012 May 1;122(5):1791-802. – doi:10.1172/JCI60975.
Antibodies Against Mutated Citrullinated Vimentin Are a Better Predictor of Disease Activity at 24 Months in Early Rheumatoid Arthritis Than Antibodies Against Cyclic Citrullinated Peptides.
J Rheumatol 2008.
Antibodies binding to citrullinated telopeptides of type I and type II collagens and to mutated citrullinated vimentin synergistically predict the development of seropositive rheumatoid arthritis.
Ann Rheum Dis 2012 Mar 14. [Epub ahead of print]
Antibodies against citrullinated vimentin in rheumatoid arthritis: Higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides.
Arthritis Rheum 2007; 58(1):36-45. – doi:10.1002/art.23188
Autoantibodies to citrullinated fibrinogen compared with anti-MCV and anti-CCP2 antibodies in diagnosing rheumatoid arthritis at an early stage: data from the French ESPOIR cohort.
Ann Rheum Dis. 2012 May 12. [Epub ahead of print]
Antibodies to Citrullinated Vimentin are a Specific and Sensitive Marker for the Diagnosis of Rheumatoid Arthritis.
Clin Rev Allergy Immunol 2008; 34(1):4-10. – doi:10.1007/s12016-007-8016-3
Meta-analysis: diagnostic value of serum anti-mutated citrullinated vimentin antibodies in patients with rheumatoid arthritis.
Rheumatol Int. 2010 Mar 10.
Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy.
Arthritis Res Ther. 2008 Dec 10;10(6):R142.
– doi:10.1186/ar2570
Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis: As Good as it Gets?
Clin Rev Allergy Immunol 2008; 34(1):26-31. – doi:10.1007/s12016-007-8022-5
Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a ten-year prospective study.
Ann Rheum Dis. 2009 Jul 30. – doi:10.1136/ard.2009.113092
The relevance of citrullinated vimentin in the production of antibodies against citrullinated proteins and the pathogenesis of rheumatoid arthritis.
Rheumatology (Oxf ord). 2011 May; 50(5): 830–837. – doi:10.1093/rheumatology/keq419
Antibody against mutated citrullinated vimentin: a sensitive marker in the diagnosis of rheumatoid arthritis.
Rheumatol Int. 2009 Jan 28 – doi:10.1007/s00296-009-0854-2
Association of Anti-Modified Citrullinated Vimentin with Subclinical Atherosclerosis in Early Rheumatoid Arthritis Compared with Anti-Cyclic Citrullinated Peptide.
J Rheumatol, 2011, 38(5):828-34 – doi:10.3899/jrheum.101143
target="_blank">more Information